%0 Journal Article
%T Second Generation Inhibitors of HIV-1 Maturation
%J -
%D 2019
%R https://doi.org/10.1021/acsmedchemlett.8b00656
%X The strategy and tactics subtending the discovery and development of the second generation HIV-1 maturation inhibitor GSK-3532795/BMS-955176, a compound that exhibits a broader spectrum of antiviral effect in vitro and in clinical studies than the prototypical maturation inhibitor bevirimat, are described
%U https://pubs.acs.org/doi/10.1021/acsmedchemlett.8b00656